Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Qiuji WuQian ChuHongyan ZhangBin YangXudong HeYahua ZhongXianglin YuanMelvin L K ChuaConghua XiePublished in: Cancer communications (London, England) (2020)